00000000nam 2200000zi 4500
0019.952986
003CaOODSP
00520250708132206
006m     o  d f      
007cr mn|||||||||
008250708e201311##onca    obs  f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay0y1
0861 |aCS82-003/2013-11-1E-PDF
1001 |aRotermann, Michelle, |eauthor.
24510|aSeroprevalence of hepatitis B and C virus infections : |bresults from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey / |cby Michelle Rotermann, Kellie Langlois, Anton Andonov and Maxim Trubnikov.
264 1|a[Ottawa] : |bStatistics Canada = Statistique Canada, |cNovember 2013.
264 4|c©2013
300 |a1 online resource (pages 3-13) : |billustration.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aHealth reports, |x1209-1367 ; |vv. 24, no. 11, [1]
500 |aIssued also in French under title: Séroprévalence des infections par le virus de l'hépatite B et par le virus de l'hépatite C : résultats de l'Enquête canadienne sur les mesures de la santé, 2007 à 2009 et 2009 à 2011.
500 |aISSN of series supplied from ISSN Portal.
500 |a"Component of Statistics Canada catalogue no. 82-003-X, Health Reports."
500 |a"Article."
500 |a"Research article."
504 |aIncludes bibliographical references.
5203 |a"Chronic hepatitis B (HBV) and C (HCV) virus infections can lead to liver failure, liver cancer, and death. In Canada, prevalence studies of HBV and HCV have been limited to regional and special populations. Data are from cycles 1 (2007 to 2009) and 2 (2009 to 2011) of the Canadian Health Measures Survey. Socio-demographic, health and lifestyle information was obtained via a household questionnaire; blood samples collected at mobile examination centres were used to identify present and resolved HBV infections, vaccine-induced HBV immunity, and HCV infections. …"--Abstract, page 3.
650 0|aHepatitis B|zCanada|vStatistics.
650 0|aHepatitis C|zCanada|vStatistics.
655 7|aStatistics|2lcgft
7102 |aStatistics Canada, |eissuing body.
77508|tSéroprévalence des infections par le virus de l'hépatite B et par le virus de l'hépatite C : |w(CaOODSP)9.952989
830#0|aHealth reports (Series)|vv. 24, no. 11, [1].|w(CaOODSP)9.950253
85640|qPDF|s1.27 MB|uhttps://publications.gc.ca/collections/collection_2025/statcan/82-003-x/CS82-003-2013-11-1-eng.pdf
8564 |qHTML|sN/A|uhttps://www150.statcan.gc.ca/n1/pub/82-003-x/2013011/article/11876-eng.htm
986 |a82-003-X